Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06321107
Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the safety of a single injection of GenSci094 during Controlled Ovarian Stimulation up to 1 year old of the infants from previous studies.
Official title: A Phase II/III Extension Study Comparing the Long-term Safety of GenSci094 and Gonal-f® in Chinese ART Patients
Key Details
Gender
FEMALE
Age Range
20 Years - 39 Years
Study Type
OBSERVATIONAL
Enrollment
158
Start Date
2024-03-01
Completion Date
2025-10-31
Last Updated
2025-04-08
Healthy Volunteers
Not specified
Conditions
Locations (1)
The Sixth Affiliated Hospital, Sun Yat-sen University Guangdong Gastrointestinal Hospital
Guangzhou, Guangdong, China